| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 Aug 2025 | 4 Aug 2025 |
| Quarterly Results Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve 1.To consider and approve the Un-Audited Financial Results of the Company for the first Quarter ended on 30th June, 2025 along with Limited Review Report thereon. 2. To consider other routine matters with the permission of the chair. (As Per BSE Announcement Dated on :04.08.2025) | ||
| Board Meeting | 4 Aug 2025 | 4 Aug 2025 |
| Outcome of Board Meeting held on Monday 04th August, 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | ||
| Board Meeting | 30 May 2025 | 22 May 2025 |
| Biofil Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve Intimation for meeting of Board of the Directors (Serial No.02/2025-26) of the Company scheduled to be held on Friday 30th May 2025 pursuant to the Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015. Outcome of Board Meeting held on Friday 30th May, 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As per BSE Announcement Dated on 30/05/2025) | ||
| Board Meeting | 11 Feb 2025 | 4 Feb 2025 |
| BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Intimation for Board Meeting to be held to consider Unaudited Financial Results for the Quarter ended 31st December 2024 alongwith other routine businesses. Outcome of Board meeting held on 11.02.2025 (As per BSE Announcement Dated on 11/02/2025) | ||
| Board Meeting | 30 Dec 2024 | 30 Dec 2024 |
| Appointment of Mr. Meet Shah (DIN: 06578351) as additional director under the catagory of promoter non executive director of the company | ||
| Board Meeting | 14 Nov 2024 | 7 Nov 2024 |
| BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Intimation for meeting of Board of Directors scheduled to be held on Thursday 14th November 2024 to consider and approve un-audited Financial Results for the quarter as well as half year ended on 30th September 2024 and other routine businesses OUTCOME OF BOARD MEETING HELD ON 14TH NOVEMBER, 2024 PURSUANT TO REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (As per BSE Announcement dated on 14/11/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.